(3 years, 9 months ago)
Commons ChamberI know how interested so many Members are in the access to and distribution of these incredibly important vaccines as part of our covid-19 response. Our £250 million of funding for the Coalition for Epidemic Preparedness Innovations is helping to develop vaccine candidates that can be scaled up and accessible for developing countries. Our commitment of up to £548 million to the COVAX AMC will contribute to the target of supplying 1 billion doses for 92 developing countries in 2021 and vaccinations for up to 500 million people. We have also worked with the World Bank to secure up to $12 billion in financing to support developing countries’ access to covid-19 vaccines, treatments and tests.